Results 271 to 280 of about 48,847 (353)
Some of the next articles are maybe not open access.

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle   +2 more
exaly  

[Arrhythmogenic anti-arrhythmia agents].

Cardiology, 1983
H, Löllgen   +5 more
openaire   +1 more source

[Ventricular cardiac arrhythmias. New anti-arrhythmia agents].

Zeitschrift fur Kardiologie, 1997
The CAST studies have shown that class I antiarrhythmic agents cause an increase in mortality in patients with ventricular tachyarrhythmias after myocardial infarction. This led to an increase in the use of class III agents. The most important class III antiarrhythmic substances are amiodarone and sotalol.
openaire   +1 more source

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano   +2 more
exaly  

An update on larynx cancer

Ca-A Cancer Journal for Clinicians, 2017
Kristin A Higgins, Nabil F Saba
exaly  

[Modern anti-arrhythmia drug agents].

Meditsinskaia sestra, 1991
Kh Kh, Shugushev, S N, Bogaeva
openaire   +1 more source

Home - About - Disclaimer - Privacy